Takeda
ELAPRASE
Manufacturer:
Takeda
Name:
ELAPRASE
HCPCS Code Descriptor:
Injection, idursulfase, 1 mg
Category:
J Code
HCPCS:
J1743
NDC(s):
54092-0700-01
Primary Type:
Enzyme Replacement Therapy
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
ELAPRASE is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J1743 is aligned to the drug ELAPRASE.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/08
HCPCS Effective Date:
1/1/08
HCPCS Short Description:
Idursulfase injection
Billing and Coding Guide:
https://www.elaprase.com/Content/pdf/resource-pdf/hcp/ELAPRASE%20Reimbursement%20Guide%20PDF.pdf
Patient Assistance:
https://www.elaprase.com/getting-started-support/onepath/